Sidewinder Therapeutics is a biotechnology company that offers life-saving therapies for cancer and rare diseases.
Sidewinder Therapeutics has raised $137.0M in total funding. The most recent round was Series B. The last funding was announced in April 2026.
Sidewinder Therapeutics's investors include DCVC Bio, Samsara BioCapital, OrbiMed, Longwood Fund, Frazier Life Sciences.
Sidewinder Therapeutics is headquartered in San Diego, United States.
Sidewinder Therapeutics is a biotechnology company that offers life-saving therapies for cancer and rare diseases.
Sidewinder Therapeutics is at the Series B stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sidewinder Therapeutics — Funding & Investors." VCBacked, April 8, 2026, https://www.vcbacked.co/company/sidewinder-therapeutics. Accessed July 27, 2026.
VCBacked. (2026). Sidewinder Therapeutics — Funding & Investors. Retrieved July 27, 2026, from https://www.vcbacked.co/company/sidewinder-therapeutics
{{cite web |title=Sidewinder Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/sidewinder-therapeutics |website=VCBacked |access-date=July 27, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated